| 标题 |
[求助补充材料]
Phase III Clinical Trial for the Combination of Erlotinib Plus Ramucirumab Compared With Osimertinib in Previously Untreated Advanced or Recurrent Non–Small Cell Lung Cancer Positive for the L858R Mutation of EGFR: REVOL858R (WJOG14420L) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Lung Cancer 作者:Naoki Haratake; Hidetoshi Hayashi; Mototsugu Shimokawa; Yusuke Nakano; Koichi Azuma; et al 出版日期:2021-10-25 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)